CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,645 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00615914
NCT00615914N/ACompleted
CompareCT.gov

Pramipexole Special Survey on Long-Term Use

Boehringer Ingelheim·observational·Posted Feb 14, 2008·Updated Jul 11, 2014

In Brief

An observational study for Parkinson Disease. Completed, enrolled 1,645 participants across 273 sites.

Detailed Summary

The survey is conducted to collect safety and effectiveness information on the use of Pramipexole for long time of period in daily clinical settings in Japan.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 14, 2008
Enrollment StartFeb 1, 2004
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 18.4 years ago